This review highlights the potential of targeting ion channels, transporters, and pumps to treat reduced contractility and arrhythmias in congestive heart failure.
Targets for HF contractility and arrhythmias remain hypothesis-generating; leaves open translation to practice.
Congestive heart failure is a leading cause of morbidity and mortality. Congestive heart failure is marked by atrial and ventricular enlargements and reduced cardiac contractility and an association with an increased incidence of atrial and ventricular arrhythmias and sudden cardiac death. Dysfunctional ion channel function is one of the major underlying mechanisms of the reduced contractility and arrhythmias. In this review, we explore the utility of ion channels, transporters, and pumps as targets for the treatment of heart failure, focusing predominantly on the treatment for reduced contractility and arrhythmias.
No takes yet. Share an insight, caveat, or question.
Doshi et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: